Research Article

Outcomes of Emergency Transcatheter Aortic Valve Replacement

Table 4

Procedural characteristics.

Procedural indication
 Primary aortic stenosis, n (%)27 (87.0)
 Primary aortic insufficiency, n (%)3 (9.7)
 Mixed aortic stenosis/insufficiency, n (%)1 (3.2)

Device used
 Balloon-expandable valve, n (%)25 (80.6)
 Self-expanding valve, n (%)5 (16.1)

Contrast volume (ml), mean (SD)97.2 (64.8)

PCI at time of TAVR, n (%)6 (19.4)

Intraprocedural CPR, n (%)6 (19.4)

MCS in place at start of TAVR10 (32.3)
 IABP, n (%)7 (22.6)
 Impella, n (%)3 (9.7)
 TandemHeart, n (%)1 (3.2)

MCS placed after TAVR deployment6 (19.4)
 IABP, n (%)2 (6.5)
 Impella, n (%)5 (16.1)
 TandemHeart, n (%)0 (0.0)

Day of procedure APACHE II score, mean (SD)13.3 (6.3)

PCI: percutaneous coronary intervention; TAVR: transcatheter aortic valve replacement; CPR: cardiopulmonary resuscitation; MCS: mechanical circulatory support; IABP: intra-aortic balloon pump; APACHE: acute physiology and chronic health evaluation.